← Eichor
Condition: Metastatic Malignant Neoplasm In The Liver Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Metastatic Malignant Neoplasm In The Liver

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Pa
Phase 3 · 60 location(s) · ECOG-ACRIN Cancer Research Group · NCT05863195Liver Transplantation for Non-Resectable Colorectal Liver Metastasis
NA · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT05185245CapTemY90 for Grade 2/3 NET Liver Metastases
Phase 2 · 4 location(s) · Abramson Cancer Center at Penn Medicine · NCT04339036Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
Phase N/A · 1 location(s) · University of Missouri-Columbia · NCT02838836TRANsplantation vs reSECTion After Conversion Therapy for Initially Unresectable Colorectal Liver Metastases
NA · 1 location(s) · Niguarda Hospital · NCT07607873A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves T
Phase 1 · 11 location(s) · AbbVie · NCT06487559Prospective Cohort Study on the Relationship Between Exosomal Peroxiredoxin 1 (PRDX1) and Postoperative Liver Metastasis
Phase N/A · 1 location(s) · Mu-qing Yang · NCT07177742Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer
Phase N/A · 1 location(s) · Helse Stavanger HF · NCT01762813Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Br
Phase 2 · 1 location(s) · City of Hope Medical Center · NCT06860815Ivonescimab Plus Chemotherapy in Patients With Initially Unresectable Colorectal Cancer Liver Metastases
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06848842INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastases
EARLY_Phase 1 · 1 location(s) · Northwell Health · NCT07172282Pancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOX
NA · 1 location(s) · Laval University · NCT06349278Liver Transplantation Compared to Chemotherapy in Patients With ColoRectal Cancer
NA · 1 location(s) · Oslo University Hospital · NCT03494946DEBIRI Plus Chemotherapy vs. Chemotherapy Alone in Colorectal Cancer Liver Metastases
Phase 3 · 1 location(s) · Tehran University of Medical Sciences · NCT06555003Safety of HRX215 in Patients After Minor and Major Liver Resection
Phase 1/Phase 2 · 12 location(s) · HepaRegeniX GmbH · NCT06638502The Role of the Imaging FAPI PET/CT in Exploring the Microenvironment of Colorectal Cancer Liver Metastases
NA · 1 location(s) · Jules Bordet Institute · NCT07109440Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Phase 1/Phase 2 · 26 location(s) · Tango Therapeutics, Inc. · NCT05732831Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
NA · 2 location(s) · University of California, San Francisco · NCT04221893Cryoablation Combined with Sintilimab Plus Lenvatinib in Previously Treated Unresectable Liver Metastasis from Solid Tum
Phase 2 · 1 location(s) · Fudan University · NCT05098847FDG PET-CT in Advanced Breast Cancer
Phase N/A · 1 location(s) · Samsung Medical Center · NCT07173868Feasibility of Circulating Tumour DNA (ctDNA) Analysis Using Automated Capillary Blood Sampling
Phase N/A · 1 location(s) · Erasmus Medical Center · NCT07310537LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis
Phase 1 · 2 location(s) · Daping Hospital and the Research Institute of Surgery of the · NCT06848465Multimodal Prehabilitation During Chemotherapy in Patients With Colorectal Liver Metastases
NA · 1 location(s) · Institut Investigacio Sanitaria Pere Virgili · NCT04520737TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors
NA · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT06487663Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)
Phase N/A · 9 location(s) · Sirtex Medical · NCT05967143Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treat
Phase 2 · 14 location(s) · Delcath Systems Inc. · NCT06607458Selective Internal Radiation Therapy With 90Y Resin Micropheres for Refractory Colorectal Cancer Liver Metastases
Phase N/A · 1 location(s) · Aarhus University Hospital · NCT04491929Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC
Phase 2 · 1 location(s) · National Cancer Centre, Singapore · NCT04912765Tumor Antigen-sensitized DC Vaccine for Colorectal Cancer Liver Metastases
Phase 1 · 1 location(s) · West China Hospital · NCT06545630Proton Therapy in the Treatment of Liver Metastases
NA · 1 location(s) · Loma Linda University · NCT01697371
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.